Patent · US Active

Engineered enzymes

US11345903B2 · kind B2 · utility

1Cited by
17References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 19, 2020
Grant dateMay 31, 2022
Priority date—
Expiry dateFeb 3, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/22
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides engineered RNA-guided enzymes for editing live cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.